Advertisement
Advertisement
Doiz

Doiz

itopride

Manufacturer:

Siam Bheasach

Distributor:

Siam Pharmaceutical
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Contents
Itopride hydrochloride.
Description
A white to off-white, round, biconvex film-coated tablet, with "
Click on icon to see table/diagram/image
" logo on one side and "I" on the other side.
Each tablet contains 50 mg of Itopride hydrochloride.
Action
Pharmacology: Pharmacodynamics: Itopride is a substituted benzamide that has been used for prokinetic agent and antiemetic agent. Itopride acts as the dopamine receptor (D2 subtype) antagonist. It also acts as acetylcholine esterase inhibitor leading to the elevation of acetylcholine level and gastrointestinal motility.
Pharmacokinetics: Absorption: Itopride is absorbed rapidly by oral administration. The peak plasma concentration occurred within 0.50-0.66 hour. The bioavailability is calculated to be 60%.
Distribution: 96% of Itopride is bound to plasma proteins.
Metabolism: Itopride undergoes N-oxidation via flavine monooxygenase enzymes (FMO1 and FMO3).
Elimination: Itopride is excreted into urine as main metabolite and unchanged drug, in amount of 68% and 4% respectively. The half-life elimination of Itopride is 5.7±0.3 hours.
Indications/Uses
Itopride is used for management of gastrointestinal symptoms of functional (non-ulcer) dyspepsia, chronic gastritis and symptoms cause by gastric dysmotility and delayed gastric emptying, like sensation of bloating, early satiety, postprandial fullness, upper abdominal pain or discomfort, anorexia, heartburn, nausea and vomiting.
Dosage/Direction for Use
Administer orally before meals. Itopride should be given 50 mg 3 times daily.
Overdosage
There have been no reports of overdose in humans. The oral single dose LD50 was more than 2000 mg/kg in mice and rats and about 600 mg/kg in dogs. In case of excessive overdose, the usual measures of gastric lavage and symptomatic therapy should be applied.
Contraindications
Itopride should be avoided in patients who are hypersensitive to Itopride and any component in the formulation.
Patients with gastrointestinal hemorrhage, mechanical obstruction or gastrointestinal perforation may also avoid using Itopride.
Special Precautions
Itopride enhances the action of acetylcholine and may produce cholinergic side effects.
Use in the Elderly: Use caution in elderly due to increased risk of adverse effect; may require dose reduction.
Use In Pregnancy & Lactation
Pregnancy: There are no published safety data in pregnant women. If treatment of GI symptoms is required during pregnancy, other agent may be preferred.
Lactation: It is not known if Itopride is excreted in breast milk. If use of Itopride is required, breast-feeding should be avoided.
Adverse Reactions
Abdominal pain, constipation, diarrhea, increased serum prolactin, nausea, skin rash, headache, irritability, tremor, increased serum alkaline phosphatase, increased blood urea nitrogen, increased serum creatinine, back pain, chest pain, fatigue, erythema, anaphylaxis, gynecomastia, hepatic insufficiency, increased gamma-glutamyl transferase, increased serum ALT, increased serum AST, jaundice, leukopenia, pruritus, sialorrhea, shock, sleep disorder, thrombocytopenia.
Drug Interactions
There are no known interactions where it is recommended to avoid concomitant use.
The effect of Itopride may be decreased by anticholinergic agents.
Storage
Store below 30°C.
MIMS Class
GIT Regulators, Antiflatulents & Anti-Inflammatories / Antiemetics
ATC Classification
A03FA07 - itopride ; Belongs to the class of propulsives. Used in the treatment of functional gastrointestinal disorders.
Presentation/Packing
Form
Doiz FC tab 50 mg
Packing/Price
1 × 10's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement